Multiple Sclerosis Clinical Trials in Philadelphia

Showing 321-340 of 358 trials

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

NCT00076011

The primary purpose of this protocol is to determine the activity of AG 013736 in patients with metastatic renal cell cancer who have received 1 prior cytokine-based therapy.

Kidney Neoplasms

Pfizer52 participantsStarted Oct 2003

San Francisco, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +6 more locations

COMPLETEDPHASE2< 1 mile

Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

NCT00094055

This is a Phase 2 study being conducted at multiple centers in the United States. Patients having thyroid cancer that has spread to other parts of the body (i.e., metastatic) are eligible to participate. Patients must have disease that was not controlled by previous treatment with radioactive iodine (131I) or not be good candidates for such treatment. The purpose of the study is to test whether the angiogenesis inhibitor AG-013736 is an effective treatment for metastatic thyroid cancer as shown by the number of patients in the study who experience significant and durable tumor shrinkage.

Thyroid Neoplasms

Pfizer60 participantsStarted Sep 2004

Santa Monica, California, United States • Aurora, Colorado, United States • Denver, Colorado, United States +6 more locations

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Multiple Sclerosis Trials in Other Cities

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

A Study Of PF-03732010 In Patients With Advanced Solid Tumors

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy

TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

A Phase III Trial For Patients With Metastatic Breast Cancer

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy

Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer

Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Other Conditions in Philadelphia